NattoPharma ASA announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced total revenue was NOK 62.779 million compared to NOK 39.278 million a year ago. Operating income was NOK 9.822 million compared to NOK 274,000 a year ago. Net income was NOK 38.262 million compared to net loss of NOK 15.154 million a year ago. Basic earnings per share from continuing operations was NOK 1.93 compared to basic loss per share from continuing operations of NOK 0.83 a year ago. Diluted earnings per share from continuing operations was NOK 1.83 compared to diluted loss per share from continuing operations of NOK 0.83 a year ago. For the full year, total revenue was NOK 217.967 million compared to NOK 131.150 million a year ago. Net income was NOK 69.150 million compared to net loss of NOK 13.696 million a year ago. Basic earnings per share from continuing operations was NOK 3.52 compared to basic loss per share from continuing operations of NOK 0.75 a year ago. Diluted earnings per share from continuing operations was NOK 3.34 compared to diluted loss per share from continuing operations of NOK 0.75 a year ago.